Last 12 months
Inside the activity.
0 purchase rows · 74 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 7 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2025 Filed Nov 13, 2025 18:35 UTC |
Leonard Keith RDirector
|
GiftCommon Stock | 1,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001416180-25-000007 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 739 F1 · kind: The filer gifted shares to a CRUT. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 636 | $0.00 Strike: $347.42 | $0.00 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · derivative · entry 13 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,929 Underlying: Common Stock · 636 shares Expires 2031-08-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,565 | $0.00 Strike: $245.60 | $0.00 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · derivative · entry 12 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,565 shares Expires 2031-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,898 | $0.00 Strike: $242.34 | $0.00 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · derivative · entry 11 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,898 shares Expires 2030-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,901 | $0.00 Strike: $177.99 | $0.00 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · derivative · entry 10 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,901 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
SaleCommon Stock | 4,731 | $580.00 | $2,743,980.00 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · nonDerivative · entry 9 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,056 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
SaleCommon Stock | 2,901 | $580.00 | $1,682,580.00 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · nonDerivative · entry 8 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,787 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
Exercise / conversionCommon Stock | 2,901 | $177.99 | $516,339.42 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · nonDerivative · entry 7 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
SaleCommon Stock | 2,898 | $580.00 | $1,680,840.00 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · nonDerivative · entry 6 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,787 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
Exercise / conversionCommon Stock | 2,898 | $242.34 | $702,291.76 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · nonDerivative · entry 5 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
SaleCommon Stock | 2,565 | $580.00 | $1,487,700.00 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · nonDerivative · entry 4 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,787 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
Exercise / conversionCommon Stock | 2,565 | $245.60 | $629,964.00 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · nonDerivative · entry 3 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
SaleCommon Stock | 636 | $580.00 | $368,880.00 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · nonDerivative · entry 2 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,787 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:55 UTC |
Charlton Henry LEVP & Chief Commercial and Mkt
|
Exercise / conversionCommon Stock | 636 | $347.42 | $220,957.02 |
DisclosureSEC source: 0001897642-25-000004 · edgardoc.xml · nonDerivative · entry 1 Charlton Henry L · CIK 0001897642 · EVP & Chief Commercial and Mkt 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2026. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 19:12 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 105 | $0.00 Strike: $229.39 | $0.00 |
DisclosureSEC source: 0001632901-25-000006 · edgardoc.xml · derivative · entry 4 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,571 Underlying: Common Stock · 105 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. F2 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 19:12 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 105 | $560.00 | $58,800.00 |
DisclosureSEC source: 0001632901-25-000006 · edgardoc.xml · nonDerivative · entry 2 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 19:12 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 105 | $229.39 | $24,085.95 |
DisclosureSEC source: 0001632901-25-000006 · edgardoc.xml · nonDerivative · entry 1 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 19:03 UTC |
Miller Brian EdwardEVP & Chief Digital Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,298 | $0.00 Strike: $229.39 | $0.00 |
DisclosureSEC source: 0002010301-25-000004 · edgardoc.xml · derivative · entry 6 Miller Brian Edward · CIK 0002010301 · EVP & Chief Digital Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,602 Underlying: Common Stock · 1,298 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025. F3 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 19:03 UTC |
Miller Brian EdwardEVP & Chief Digital Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,202 | $0.00 Strike: $208.90 | $0.00 |
DisclosureSEC source: 0002010301-25-000004 · edgardoc.xml · derivative · entry 5 Miller Brian Edward · CIK 0002010301 · EVP & Chief Digital Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,115 Underlying: Common Stock · 2,202 shares Expires 2029-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 19:03 UTC |
Miller Brian EdwardEVP & Chief Digital Officer
|
SaleCommon Stock | 2,202 | $575.00 | $1,266,150.00 |
DisclosureSEC source: 0002010301-25-000004 · edgardoc.xml · nonDerivative · entry 4 Miller Brian Edward · CIK 0002010301 · EVP & Chief Digital Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,758 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 19:03 UTC |
Miller Brian EdwardEVP & Chief Digital Officer
|
Exercise / conversionCommon Stock | 2,202 | $208.90 | $459,997.80 |
DisclosureSEC source: 0002010301-25-000004 · edgardoc.xml · nonDerivative · entry 3 Miller Brian Edward · CIK 0002010301 · EVP & Chief Digital Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 19:03 UTC |
Miller Brian EdwardEVP & Chief Digital Officer
|
SaleCommon Stock | 1,298 | $575.00 | $746,350.00 |
DisclosureSEC source: 0002010301-25-000004 · edgardoc.xml · nonDerivative · entry 2 Miller Brian Edward · CIK 0002010301 · EVP & Chief Digital Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,758 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 19:03 UTC |
Miller Brian EdwardEVP & Chief Digital Officer
|
Exercise / conversionCommon Stock | 1,298 | $229.39 | $297,748.22 |
DisclosureSEC source: 0002010301-25-000004 · edgardoc.xml · nonDerivative · entry 1 Miller Brian Edward · CIK 0002010301 · EVP & Chief Digital Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 19:17 UTC |
Widman FredrikVP Corporate Controller
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,908 | $0.00 Strike: $77.00 | $0.00 |
DisclosureSEC source: 0001897970-25-000003 · edgardoc.xml · derivative · entry 6 Widman Fredrik · CIK 0001897970 · VP Corporate Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,908 shares Expires 2026-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 21, 2026. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 19:17 UTC |
Widman FredrikVP Corporate Controller
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 159 | $0.00 Strike: $59.46 | $0.00 |
DisclosureSEC source: 0001897970-25-000003 · edgardoc.xml · derivative · entry 5 Widman Fredrik · CIK 0001897970 · VP Corporate Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 159 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 21, 2026. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 19:17 UTC |
Widman FredrikVP Corporate Controller
|
SaleCommon Stock | 159 | $550.00 | $87,450.00 |
DisclosureSEC source: 0001897970-25-000003 · edgardoc.xml · nonDerivative · entry 4 Widman Fredrik · CIK 0001897970 · VP Corporate Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 473 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 21, 2026. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 19:17 UTC |
Widman FredrikVP Corporate Controller
|
Exercise / conversionCommon Stock | 159 | $59.46 | $9,454.49 |
DisclosureSEC source: 0001897970-25-000003 · edgardoc.xml · nonDerivative · entry 3 Widman Fredrik · CIK 0001897970 · VP Corporate Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 21, 2026. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 19:17 UTC |
Widman FredrikVP Corporate Controller
|
SaleCommon Stock | 1,908 | $550.00 | $1,049,400.00 |
DisclosureSEC source: 0001897970-25-000003 · edgardoc.xml · nonDerivative · entry 2 Widman Fredrik · CIK 0001897970 · VP Corporate Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 473 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 21, 2026. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 19:17 UTC |
Widman FredrikVP Corporate Controller
|
Exercise / conversionCommon Stock | 1,908 | $77.00 | $146,913.90 |
DisclosureSEC source: 0001897970-25-000003 · edgardoc.xml · nonDerivative · entry 1 Widman Fredrik · CIK 0001897970 · VP Corporate Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 21, 2026. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 22:21 UTC |
Rosa David J.Director · Chief Executive Officer (CEO)
|
GiftCommon Stock | 5,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001519593-25-000006 · edgardoc.xml · nonDerivative · entry 1 Rosa David J. · CIK 0001519593 · Director · Chief Executive Officer (CEO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,802 F1 · kind: The filer gifted shares to The Rosa Donor Advised Fund. Read SEC document |
| October 29, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 125 | $0.00 Strike: $208.90 | $0.00 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · derivative · entry 11 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 501 Underlying: Common Stock · 125 shares Expires 2029-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| October 29, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 125 | $543.00 | $67,875.00 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · nonDerivative · entry 8 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. Read SEC document |
| October 29, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 125 | $208.90 | $26,112.50 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · nonDerivative · entry 7 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,030 | $0.00 Strike: $242.34 | $0.00 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · derivative · entry 13 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,030 shares Expires 2030-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,153 | $0.00 Strike: $229.39 | $0.00 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · derivative · entry 12 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,676 Underlying: Common Stock · 1,153 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. F4 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,379 | $0.00 Strike: $208.90 | $0.00 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · derivative · entry 10 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 626 Underlying: Common Stock · 1,379 shares Expires 2029-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 1,379 | $548.43 | $756,278.63 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · nonDerivative · entry 6 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 353 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $545.57 to $551.71 as follows: 1,173 shares sold at $545.57 to $546.54; 2,460 shares sold at $546.69 to $547.63; 314 shares sold at $547.72 to $548.68; 2,610 shares sold at $549.26 to $550.21; 1,000 shares sold at $550.39 to $551.04; 5 shares sold at $551.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,379 | $208.90 | $288,073.10 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · nonDerivative · entry 5 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 1,153 | $548.43 | $632,334.49 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · nonDerivative · entry 4 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 353 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $545.57 to $551.71 as follows: 1,173 shares sold at $545.57 to $546.54; 2,460 shares sold at $546.69 to $547.63; 314 shares sold at $547.72 to $548.68; 2,610 shares sold at $549.26 to $550.21; 1,000 shares sold at $550.39 to $551.04; 5 shares sold at $551.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,153 | $229.39 | $264,486.67 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · nonDerivative · entry 3 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 5,030 | $548.43 | $2,758,579.76 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · nonDerivative · entry 2 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 353 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $545.57 to $551.71 as follows: 1,173 shares sold at $545.57 to $546.54; 2,460 shares sold at $546.69 to $547.63; 314 shares sold at $547.72 to $548.68; 2,610 shares sold at $549.26 to $550.21; 1,000 shares sold at $550.39 to $551.04; 5 shares sold at $551.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 23:48 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 5,030 | $242.34 | $1,218,953.60 |
DisclosureSEC source: 0001632901-25-000004 · edgardoc.xml · nonDerivative · entry 1 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 19:56 UTC |
BARRATT CRAIG HDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,193 | $0.00 Strike: $71.32 | $0.00 |
DisclosureSEC source: 0001277620-25-000005 · edgardoc.xml · derivative · entry 4 BARRATT CRAIG H · CIK 0001277620 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 2,193 shares Expires 2026-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2026. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 19:56 UTC |
BARRATT CRAIG HDirector
|
SaleCommon Stock | 2,193 | $548.01 | $1,201,785.93 |
DisclosureSEC source: 0001277620-25-000005 · edgardoc.xml · nonDerivative · entry 2 BARRATT CRAIG H · CIK 0001277620 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2026. Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 19:56 UTC |
BARRATT CRAIG HDirector
|
Exercise / conversionCommon Stock | 2,193 | $71.32 | $156,412.00 |
DisclosureSEC source: 0001277620-25-000005 · edgardoc.xml · nonDerivative · entry 1 BARRATT CRAIG H · CIK 0001277620 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2026. Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 20:11 UTC |
GUTHART GARY SDirector · Executive Chair of the Board o
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $109.49 | $0.00 |
DisclosureSEC source: 0001280628-25-000004 · edgardoc.xml · derivative · entry 6 GUTHART GARY S · CIK 0001280628 · Director · Executive Chair of the Board o 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2027-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026. F5 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 20:11 UTC |
GUTHART GARY SDirector · Executive Chair of the Board o
|
SaleCommon Stock | 1,400 | $546.18 | $764,657.60 |
DisclosureSEC source: 0001280628-25-000004 · edgardoc.xml · nonDerivative · entry 4 GUTHART GARY S · CIK 0001280628 · Director · Executive Chair of the Board o 10b5-1 filing: Plan reported Ownership: Indirect · Trust FBO Son Disclosed balance after: 17,120 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $542.16 to $548.45 as follows: 190 shares sold at $542.16 to $542.98; 150 shares sold at $543.79 to $544.30; 190 shares sold at $545.00 to $545.33; 292 shares sold at $546.34 to $547.20; and 578 shares sold at $547.51 to $548.45. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 20:11 UTC |
GUTHART GARY SDirector · Executive Chair of the Board o
|
SaleCommon Stock | 1,400 | $546.35 | $764,889.86 |
DisclosureSEC source: 0001280628-25-000004 · edgardoc.xml · nonDerivative · entry 3 GUTHART GARY S · CIK 0001280628 · Director · Executive Chair of the Board o 10b5-1 filing: Plan reported Ownership: Indirect · Trust FBO Daughter Disclosed balance after: 17,120 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $542.74 to $548.48 as follows: 100 shares sold at $542.74; 205 shares sold at $543.97 to $544.45; 250 shares sold at $545.06 to $545.94; 200 shares sold at $546.46 to $546.75; and 645 shares sold at $547.49 to $548.48. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 20:11 UTC |
GUTHART GARY SDirector · Executive Chair of the Board o
|
SaleCommon Stock | 28,800 | $547.56 | $15,769,644.48 |
DisclosureSEC source: 0001280628-25-000004 · edgardoc.xml · nonDerivative · entry 2 GUTHART GARY S · CIK 0001280628 · Director · Executive Chair of the Board o 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,027 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $541.76 to $550.16 as follows: 800 shares sold at $541.76 to $542.59; 1,000 shares sold at $542.89 to $543.22; 2,563 shares sold at $544 to $545; 1,600 shares sold at $545.33 to $546.29; 2,770 shares sold at $546.34 to $547.19; 7,383 shares sold at $547.35 to $548.31; 9,068 shares sold at $548.36 to $549.35; and 3,616 shares sold at $549.485 to $550.16. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 20:11 UTC |
GUTHART GARY SDirector · Executive Chair of the Board o
|
Exercise / conversionCommon Stock | 36,000 | $109.49 | $3,941,481.60 |
DisclosureSEC source: 0001280628-25-000004 · edgardoc.xml · nonDerivative · entry 1 GUTHART GARY S · CIK 0001280628 · Director · Executive Chair of the Board o 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.